Artivion | CRY - Ebitda

Precio De Mercado
38.40
Cambio Diario
1.66 4.52%
Mensual
4.72%
Anual
70.44%
Q2 Expectativa
36.60




Ebitda Cambio Fecha
Abbott USD 3.27B 178M 2025-12
Accuray USD -685K 900K 2024-09
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Integra LifeSciences USD 104.21M 25.76M 2025-12
J&J USD 7.19B 2.32B 2025-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Orthofix International USD 27.88M 2.77M 2025-12
Pfizer USD 6.08B 351M 2025-09
ResMed USD 547.48M 27.46M 2025-12
Stryker USD 1.67B 206M 2025-09
Surmodics USD 3.43M 1.9M 2025-06
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Trinity Biotech USD -9.6M 7.64M 2024-12